Evidence map›Paper›PMID 27511963›Full record

ArticleCellular signalling2017

Establishing estrogen-responsive mouse mammary organoids from single Lgr5

Lixing Zhang, Mohammad Adileh, Maria Laura Martin, Stefan Klingler, Julie White, Xiaojing Ma, Louise R Howe, Anthony M C Brown, Richard Kolesnick

Open access · greenAbstract read
In one paragraph

Article in Cellular signalling, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Engineering organoids.Nature reviews. Materials · 2021
    Review
  14. Article
  15. Review
  16. Article
  17. Progress in the application of organoids to breast cancer research.Journal of cellular and molecular medicine · 2020
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Lixing ZhangSchool of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai 200240, China; Laboratory of Signal Transduction, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Cell & Developmental Biology, Weill Cornell Medical College, New York, NY 10065, USA.
Mohammad AdilehLaboratory of Signal Transduction, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Maria Laura MartinLaboratory of Signal Transduction, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Stefan KlinglerLaboratory of Signal Transduction, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Julie WhiteTri-Institutional Laboratory of Comparative Pathology & Genetically Engineered Mouse Phenotyping Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Xiaojing MaSchool of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai 200240, China; Department of Microbiology & Immunology, Weill Cornell Medical College, New York, NY 10065, USA.
Louise R HoweDepartment of Cell & Developmental Biology, Weill Cornell Medical College, New York, NY 10065, USA.
Anthony M C BrownDepartment of Cell & Developmental Biology, Weill Cornell Medical College, New York, NY 10065, USA; Department of Microbiology & Immunology, Weill Cornell Medical College, New York, NY 10065, USA. Electronic address: amcbrown@med.cornell.edu.
Richard KolesnickLaboratory of Signal Transduction, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address: r-kolesnick@ski-mskcc.org.
Memorial Sloan Kettering Cancer Center · USCornell University · USShanghai Jiao Tong University · CN

Funding

MECHANISMS OF INHIBITION OF IL 12 PRODUCTIONR01AI045899 · NIAID · WISTAR INSTITUTE · PI MA, XIAOJING · 1999 to 2008
$2.8M
Lgr5, mammary tumor stem cells, and radiation therapyR21CA186981 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI BROWN, ANTHONY M.C., HOWE, LOUISE R · 2014 to 2015
$428k
NCI NIH HHS R21 CA186981NIAID NIH HHS R01 AI045899
6 · The paper itself

Abstract

Recent evidence suggests that mammary cells expressing R-spondin receptor and Wnt pathway regulator Lgr5, regarded as a stem cell marker in multiple tissues, might represent mammary stem cells (MaSCs). Whether L gr5 marks a multipotent subpopulation of Lin-CD24

Indexed as

AnimalsCell DifferentiationColony-Forming Units AssayEstrogensFemaleMammary Glands, AnimalMice, Inbred C57BLOrganoidsReceptors, G-Protein-CoupledEstrogensLgr5 protein, mouseReceptors, G-Protein-CoupledLgr5(+)Mammary glandOrganoidStem cells

Identifiers

PMID27511963
PMCPMC5138122
OpenAlexW2512931273

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.